The significance of free light chain measurements in the diagnosis of myelomatous pleural effusion

Ann Hematol. 2014 Mar;93(3):507-8. doi: 10.1007/s00277-013-1818-x.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Bence Jones Protein / analysis
  • Bence Jones Protein / urine
  • Cyclophosphamide / therapeutic use
  • Dexamethasone / therapeutic use
  • Disease Progression
  • Fatal Outcome
  • Humans
  • Immunoglobulin Light Chains / analysis*
  • Immunoglobulin Light Chains / urine
  • Immunoglobulin kappa-Chains / analysis
  • Immunoglobulin lambda-Chains / analysis
  • Male
  • Middle Aged
  • Multiple Myeloma / drug therapy
  • Multiple Myeloma / physiopathology*
  • Multiple Myeloma / therapy
  • Pleural Effusion, Malignant / diagnosis*
  • Pleural Effusion, Malignant / etiology
  • Pleural Effusion, Malignant / immunology
  • Pleural Effusion, Malignant / metabolism
  • Salvage Therapy
  • Teniposide / therapeutic use

Substances

  • Immunoglobulin Light Chains
  • Immunoglobulin kappa-Chains
  • Immunoglobulin lambda-Chains
  • Dexamethasone
  • Cyclophosphamide
  • Bence Jones Protein
  • Teniposide

Supplementary concepts

  • VCD protocol